These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11233293)

  • 1. [Recent advances in research on nicotine dependence and reward mechanism].
    Miyasato K
    Nihon Yakurigaku Zasshi; 2001 Jan; 117(1):27-34. PubMed ID: 11233293
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic nicotine stimulates dopamine release in nucleus accumbens: re-evaluation of the role of N-methyl-D-aspartate receptors in the ventral tegmental area.
    Fu Y; Matta SG; Gao W; Brower VG; Sharp BM
    J Pharmacol Exp Ther; 2000 Aug; 294(2):458-65. PubMed ID: 10900219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of alpha7 nicotinic receptors in nicotine dependence and implications for psychiatric illness.
    Nomikos GG; Schilström B; Hildebrand BE; Panagis G; Grenhoff J; Svensson TH
    Behav Brain Res; 2000 Aug; 113(1-2):97-103. PubMed ID: 10942036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Full-gestational exposure to nicotine and ethanol augments nicotine self-administration by altering ventral tegmental dopaminergic function due to NMDA receptors in adolescent rats.
    Roguski EE; Sharp BM; Chen H; Matta SG
    J Neurochem; 2014 Mar; 128(5):701-12. PubMed ID: 24147868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct effect of nicotine on mesolimbic dopamine release in rat nucleus accumbens shell.
    Kleijn J; Folgering JH; van der Hart MC; Rollema H; Cremers TI; Westerink BH
    Neurosci Lett; 2011 Apr; 493(1-2):55-8. PubMed ID: 21352892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinforcing effects of nicotine microinjections into the ventral tegmental area of mice: dependence on cholinergic nicotinic and dopaminergic D1 receptors.
    David V; Besson M; Changeux JP; Granon S; Cazala P
    Neuropharmacology; 2006 Jun; 50(8):1030-40. PubMed ID: 16580026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of nicotinic acetylcholine or dopamine D1-like receptors in the central nucleus of the amygdala or the bed nucleus of the stria terminalis does not precipitate nicotine withdrawal in nicotine-dependent rats.
    Jonkman S; Markou A
    Neurosci Lett; 2006 May; 400(1-2):140-5. PubMed ID: 16563623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effects of ventral tegmental area NMDA and acetylcholine receptor blockade on conditioned reinforcement produced by food-associated cues.
    Wickham RJ; Solecki WB; Nunes EJ; Addy NA
    Neuroscience; 2015 Aug; 301():384-94. PubMed ID: 26093048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nicotine-induced dopamine release in the nucleus accumbens is inhibited by the novel AMPA antagonist ZK200775 and the NMDA antagonist CGP39551.
    Kosowski AR; Cebers G; Cebere A; Swanhagen AC; Liljequist S
    Psychopharmacology (Berl); 2004 Aug; 175(1):114-23. PubMed ID: 15088078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tribute to: Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area [William Corrigall, Kathleen Coen and Laurel Adamson, Brain Res. 653 (1994) 278-284].
    Leri F; Vaccarino FJ
    Brain Res; 2016 Aug; 1645():61-4. PubMed ID: 26867702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic receptors in the ventral tegmental area.
    Nisell M; Nomikos GG; Svensson TH
    Synapse; 1994 Jan; 16(1):36-44. PubMed ID: 8134899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurobiological bases for the pharmacotherapy of nicotine addiction.
    Di Matteo V; Pierucci M; Di Giovanni G; Benigno A; Esposito E
    Curr Pharm Des; 2007; 13(12):1269-84. PubMed ID: 17504235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of methyllycaconitine (MLA), an alpha 7 nicotinic receptor antagonist, on nicotine- and cocaine-induced potentiation of brain stimulation reward.
    Panagis G; Kastellakis A; Spyraki C; Nomikos G
    Psychopharmacology (Berl); 2000 May; 149(4):388-96. PubMed ID: 10867966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies.
    McBride WJ; Murphy JM; Ikemoto S
    Behav Brain Res; 1999 Jun; 101(2):129-52. PubMed ID: 10372570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine-induced Fos expression in the nucleus accumbens and the medial prefrontal cortex of the rat: role of nicotinic and NMDA receptors in the ventral tegmental area.
    Schilström B; De Villiers S; Malmerfelt A; Svensson TH; Nomikos GG
    Synapse; 2000 Jun; 36(4):314-21. PubMed ID: 10819909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Examination of the metabolite hydroxybupropion in the reinforcing and aversive stimulus effects of nicotine in rats.
    Malcolm E; Carroll FI; Blough B; Damaj MI; Shoaib M
    Psychopharmacology (Berl); 2015 Aug; 232(15):2763-71. PubMed ID: 25761841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bupropion inhibits the cellular effects of nicotine in the ventral tegmental area.
    Mansvelder HD; Fagen ZM; Chang B; Mitchum R; McGehee DS
    Biochem Pharmacol; 2007 Oct; 74(8):1283-91. PubMed ID: 17868653
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotine and food induced dopamine release in the nucleus accumbens of the rat: putative role of alpha7 nicotinic receptors in the ventral tegmental area.
    Schilström B; Svensson HM; Svensson TH; Nomikos GG
    Neuroscience; 1998 Aug; 85(4):1005-9. PubMed ID: 9681941
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion.
    Cryan JF; Gasparini F; van Heeke G; Markou A
    Drug Discov Today; 2003 Nov; 8(22):1025-34. PubMed ID: 14690633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell.
    Paterson NE; Balfour DJ; Markou A
    Eur J Neurosci; 2007 May; 25(10):3099-108. PubMed ID: 17561823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.